These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4846326)

  • 1. Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines.
    Waldeck B
    Psychopharmacologia; 1974 Apr; 36(3):209-20. PubMed ID: 4846326
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
    Strömbom U; Svensson TH; Carlsson A
    Psychopharmacology (Berl); 1977 Mar; 51(3):293-9. PubMed ID: 403547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
    Engström G; Svensson TH; Waldeck B
    Brain Res; 1974 Sep; 77(3):471-83. PubMed ID: 4855210
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the caffeine-induced locomotor stimulation by a cholinergic mechanism.
    Waldeck B
    J Neural Transm; 1974; 35(3):197-205. PubMed ID: 4427109
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U; Waldeck B
    J Neural Transm; 1973; 34(4):241-52. PubMed ID: 4359657
    [No Abstract]   [Full Text] [Related]  

  • 7. On the interaction between caffeine and barbiturates with respect to locomotor activity and brain catecholamines.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):172-80. PubMed ID: 1173516
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of caffeine on locomotor activity and central catecholamine mechanisms: a study with special reference to drug interaction.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 4):1-23. PubMed ID: 1080339
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
    Carlsson A; Engel J; Strömbom U; Svensson TH; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):117-28. PubMed ID: 4278296
    [No Abstract]   [Full Text] [Related]  

  • 11. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitization by caffeine of central catecholamine receptors.
    Waldeck B
    J Neural Transm; 1973; 34(1):61-72. PubMed ID: 4714594
    [No Abstract]   [Full Text] [Related]  

  • 13. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased accumulation of ( 3 H) catecholamines formed from ( 3 H) dopa after treatment with caffeine and aminophylline.
    Waldeck B
    J Pharm Pharmacol; 1972 Aug; 24(8):654-5. PubMed ID: 4403749
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of ethanol's central stimulation by catecholamine receptor agonists.
    Svensson TH; Engberg G
    Adv Exp Med Biol; 1980; 126():535-50. PubMed ID: 6773308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G; Pletscher A; Burkard WP
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 19. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 20. Energy drink constituents (caffeine and taurine) selectively potentiate ethanol-induced locomotion in mice.
    Ulenius L; Adermark L; Söderpalm B; Ericson M
    Pharmacol Biochem Behav; 2019 Dec; 187():172795. PubMed ID: 31669834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.